Part 524—Ophthalmic and Topical Dosage Form New Animal Drugs

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 524

Contents

• 524.86
  § 524.86 Amitraz.
• 524.154
  § 524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
• 524.155
  § 524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
• 524.230
  § 524.230 Buprenorphine.
• 524.390
  § 524.390 Chloramphenicol ophthalmic ointment.
• 524.402
  § 524.402 Chlorhexidine.
• 524.450
  § 524.450 Clotrimazole.
• 524.463
  § 524.463 Copper naphthenate.
• 524.575
  § 524.575 Cyclosporine ophthalmic ointment.
• 524.590
  § 524.590 Diclofenac.
• 524.660
  § 524.660 Dimethyl sulfoxide.
• 524.770
  § 524.770 Doramectin.
• 524.775
  § 524.775 Emodepside and praziquantel.
• 524.802
  § 524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
• 524.814
  § 524.814 Eprinomectin.
• 524.815
  § 524.815 Eprinomectin and praziquantel.
• 524.838
  § 524.838 Esafoxolaner, eprinomectin, and praziquantel.
• 524.900
  § 524.900 Famphur.
• 524.920
  § 524.920 Fenthion.
• 524.955
  § 524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
• 524.957
  § 524.957 Florfenicol, terbinafine, and mometasone otic solution.
• 524.960
  § 524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.
• 524.970
  § 524.970 Flunixin.
• Fluocinolone Topical and Otic Dosage Forms
  Fluocinolone Topical and Otic Dosage Forms Sections 524.981–524.2620